Navigation Links
Pharmacyclics Reports Results for Six and Three Months Ended December 31, 2012

in the forward-looking statements are reasonable, we cannot guarantee future results, performance or achievements and no assurance can be given that the actual results will be consistent with these forward-looking statements. For more information about the risks and uncertainties that may affect our results, please see the Risk Factors section of our filings with the Securities and Exchange Commission, including our annual report on Form 10-K and quarterly reports on Form 10-Q. We do not intend to update any of the forward-looking statements after the date of this announcement to conform these statements to actual results, to changes in management's expectations or otherwise, except as may be required by law.

Contact:Joshua T. Brumm
Executive Vice President, Finance
Phone: 408-215-3311

Ramses Erdtmann
Vice President of Investor Relations
Phone: 408-215-3325Pharmacyclics, Inc.
Condensed Consolidated Balance Sheets
(unaudited; in thousands)

 December 31,June 30, 20122012AssetsCash, cash equivalents and marketable securities 1

203,607Other current assets 2

29,3789,788Total current assets

346,492213,395Property and equipment, net

6,4033,842Other assets

2,2341,883Total assets

219,120Liabilities and Stockholders' EquityDeferred revenue - current portion

8,054Other current liabilities

21,11810,932Total current liabilities

29,25718,986Deferred revenue - non-current portion

62,56267,324Deferred rent

784687Total liabilities

92,60386,997Stockholders' equity

262,526132,123Total liabilities and stockholders' equity

219,1201Marketable securities

5,7112As of December 31, 2012 and June 30, 2012, Other current assets includes $26.6 million and $5.8 million, respectively, due to t

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Pharmacyclics Reports Fiscal 2013 First Quarter Financial Results and Multiple PCI-32765 Presentations at the 54th American Society of Hematology Annual Meeting
2. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
3. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
4. Interleukin Genetics Reports Third Quarter 2011 Financial Results
5. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
6. Nile Therapeutics Reports 2011 Third Quarter Financial Results
7. Pharmasset Reports Fiscal Year End 2011 Financial Results
8. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
9. SeraCare Reports Fiscal Year 2011 and Fourth Quarter Financial Results
10. WaferGen Reports Third Quarter 2011 Financial Results and Announces New Commercialization Strategy
11. Hadasit Bio-Holdings Ltd. Reports Significant External Financing for Portfolio Companies
Post Your Comments:
(Date:10/9/2015)... PHILADELPHIA , Oct. 9, 2015 Governor ... a clinical stage biopharmaceutical company focused on developing T-cell ... new, high-paying jobs with a new expansion project. ... great news for the commonwealth as 110 new, high-paying ... Tom Wolf . "My budget proposal includes sustained ...
(Date:10/9/2015)... CA (PRWEB) , ... October 09, 2015 , ... Leading ... study that aims to better understand the relationship between weight management and the microbiome. ... and more accurately from participants using an iPhone app. , The uBiome app is ...
(Date:10/8/2015)... , Oct. 8, 2015  ATCC, the premier global ... it has been selected by The Michael J. Fox ... lines to academic, pharmaceutical, and biotechnology organizations committed to ... the United States , and more than ... the United States , and more than ...
(Date:10/8/2015)... Texas , Oct. 8, 2015 The 2015 ... of The University of Texas at Dallas. Aziz Sancar ... UT Dallas in 1977, is one of ... how cells continuously monitor and repair damaged DNA on a molecular ... in molecular and cell biology from UT Dallas ...
Breaking Biology Technology:
... Integra Merger, IRVINE, California, October 24 IsoTis, ... announced that,it has adjourned the special meeting of stockholders ... IsoTis by Integra LifeSciences Holdings,Corporation (NASDAQ: IART ) ... as of August 6, 2007. The special meeting ...
... ALTO, Calif., Oct. 24 Jazz,Pharmaceuticals, Inc. (Nasdaq: ... quarter 2007 financial results on Tuesday, November 6, 2007,following ... host an investor conference call and live audio webcast ... 6, 2007, at 5:00 p.m.,Eastern Time/2:00 p.m. Pacific Time. ...
... 24 /PRNewswire-FirstCall/ - Atrium Innovations Inc. (TSX:,ATB) will ... 10 a.m. Eastern,time on November 8, 2007. The ... third quarter results issued earlier the previous day.,Participants ... numbers:,416-644-3418, 514-807-8791 or 800-591-7539 or via the Company,s ...
Cached Biology Technology:
(Date:9/30/2015)... Calif. , Sept. 30, 2015  With nearly ... the number of new SCIs estimated to reach 12,500 ... Southern California Resource Services for Independent Living ... ILCs in California opening doors ... range of programs and services, notably assistive technology services ...
(Date:9/29/2015)... SUNNYVALE, Calif. , Sept. 29, 2015 ... technology improves employee productivity while also saving energy ... features such as Low Power Active Mode and embedded ... workplace transformation Fujitsu today shows that ... of new and refreshed models to its enterprise desktop ...
(Date:9/28/2015)... Sept. 28, 2015  The monitoring of vital ... body temperature, is an essential component of patient ... of deterioration in a patient,s condition. However, in ... are typically taken during routine observation rounds only ... patient deteriorates between these observation rounds, the warning ...
Breaking Biology News(10 mins):
... it will expand urea deep placement (UDP)a technology that doubles ... (ha) of rice land, reaching about 1.6 million farm families, ... is the insertion of large urea briquettes into the rice ... who use UDP can increase yields by 25% while using ...
... humile, is one of the most successful invasive species in ... to its native range in South America. A new study ... findings, from researchers at the University of Illinois and the ... the Proceedings of the National Academy of Sciences. The ...
... Richard D. Smith, Battelle Fellow at the U.S. Department ... of 50 outstanding leaders in the 2007 Scientific American 50. ... key contributors in science and technology. Smith shared the ... a colleague from UCLAs David Geffen School of Medicine, Desmond ...
Cached Biology News:
... vectors are designed for enhanced translation of cloned ... rabbit reticulocyte lysate. The maps for pCITE-2b(+) and ... following exceptions: pCITE-2b(+) is a 3793 bp plasmid; ... and Xcm I sites. Subtract 7 bp from ...
Biology Products: